Free Trial

Brainstorm Cell Therapeutics (BCLI) Insider Trading & Ownership

$0.26
0.00 (-1.43%)
(As of 05:18 PM ET)

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.45%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$22,050.00
Get BCLI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCLI Insider Buying and Selling by Quarter

Brainstorm Cell Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/19/2024Ibrahim B. DagherInsiderSell63,000$0.35$22,050.00  
(Data available from 1/1/2013 forward)

BCLI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Brainstorm Cell Therapeutics includes Ibrahim B. Dagher, and Stacy Lindborg. Learn more on insiders at BCLI.

5.45% of Brainstorm Cell Therapeutics stock is owned by insiders. Learn more on BCLI's insider holdings.

The following insider purchased BCLI shares in the last 24 months: Stacy Lindborg ($20,355.00).

Insiders have purchased a total of 11,500 BCLI shares in the last 24 months for a total of $20,355.00 bought.

The following insider sold BCLI shares in the last 24 months: Ibrahim B. Dagher ($22,050.00).

Insiders have sold a total of 63,000 Brainstorm Cell Therapeutics shares in the last 24 months for a total of $22,050.00 sold.



This page (NASDAQ:BCLI) was last updated on 9/17/2024 by MarketBeat.com Staff
From Our Partners